Navigating the Latest Options for the Treatment of CKD in T2D

In this series of microlearning modules expert faculty provide insight on new evidence and treatment for chronic kidney disease in type 2 diabetes to improve kidney and cardiovascular outcomes.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

This activity is supported by independent educational grants from

Bayer HealthCare Pharmaceuticals Inc.

Boehringer Ingelheim and Eli Lilly